You have 9 free searches left this month | to do more
Showing 1 - 25 of
127 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Acute Lymphoblastic Leukemia
  • Inotuzumab ozogamicin
  • +6 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2021-06-16
Jun 16, 2021
L
Recruiting
  • Acute Lymphocytic Leukemia
  • Non-Hodgkin's Lymphoma
  • Inotuzumab Ozogamicin
  • New York, New York
  • +2 more
2021-07-12
Jul 12, 2021
M
Terminated
  • CD22 Positive
  • +2 more
  • Inotuzumab Ozogamicin
  • Houston, Texas
    M D Anderson Cancer Center
2021-03-17
Mar 17, 2021
M
Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab Ozogamicin
  • Houston, Texas
    M D Anderson Cancer Center
2021-03-04
Mar 4, 2021
D
Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Boston, Massachusetts
  • +1 more
2021-10-19
Oct 19, 2021
R
Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +7 more
  • Inotuzumab Ozogamicin
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-10-28
Oct 28, 2021
P
Approved for marketing
    • Inotuzumab Ozogamicin
    • (no location specified)
    2020-05-14
    May 14, 2020
    U
    Recruiting
    • Lymphoblastic Leukemia
    • +2 more
    • Inotuzumab ozogamicin
    • +7 more
    • Chicago, Illinois
      University of Chicago Medical Center
    2021-05-12
    May 12, 2021
    N
    Active, not recruiting
    • Precursor Cell Lymphoblastic Leukemia
    • Inotuzumab ozogamicin
    • Augsburg, Germany
    • +13 more
    2021-05-03
    May 3, 2021
    S
    Active, not recruiting
    • Acute Leukemias of Ambiguous Lineage
    • +4 more
    • Duarte, California
    • +4 more
    2021-07-16
    Jul 16, 2021
    U
    Recruiting
    • Recurrent B Acute Lymphoblastic Leukemia
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2021-11-15
    Nov 15, 2021
    U
    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • Inotuzumab ozogamicin
    • +6 more
    • Charlottesville, Virginia
    • +1 more
    2022-01-04
    Jan 4, 2022
    M
    Recruiting
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    2020-06-25
    Jun 25, 2020
    M
    Recruiting
    • Acute Lymphoblastic Leukemia
    • +3 more
    • Allogeneic Bone Marrow Transplantation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-05-07
    May 7, 2021
    P
    Completed
    • Precursor Cell Lymphoblastic Leukemia-Lymphoma
    • Inotuzumab Ozogamicin
    • Bristol, United Kingdom
    • +3 more
    2021-09-08
    Sep 8, 2021
    P
    Active, not recruiting
    • Hematologic Maligmancy
    • Inotuzumab ozogamicin
    • Seoul, Korea, Republic of
      Pfizer
    2021-11-22
    Nov 22, 2021
    N
    Withdrawn
    • Acute Lymphoblastic Leukemia
    • Tisagenlecleucel
    • +2 more
    • (no location specified)
    2020-07-07
    Jul 7, 2020
    M
    Recruiting
    • Acute Lymphoblastic Leukemia
    • Hyperbilirubinemia
    • Levocarnitine
    • Vitamin B Complex
    • Houston, Texas
      M D Anderson Cancer Center
    2020-12-02
    Dec 2, 2020
    V
    Recruiting
    • Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)
    • Inotuzumab ozogamicin (INO)
    • Amiens, France
    • +34 more
    2020-08-10
    Aug 10, 2020
    G
    Recruiting
    • Acute Lymphoid Leukemia
    • Inotuzumab Ozogamicin (IO)
    • Ancona, Italy
    • +29 more
    2021-12-31
    Dec 31, 2021
    M
    Recruiting
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +2 more
    • Blinatumomab
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-04-29
    Apr 29, 2021
    M
    Terminated
    • Acute Lymphoblastic Leukemia in Remission
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-03-18
    Mar 18, 2021
    P
    Recruiting
    • Leukemia
    • +2 more
    • inotuzumab ozogamicin-dose level 2
    • Inotuzumab ozogamicin-dose level 1
    • Los Angeles, California
    • +49 more
    2022-01-04
    Jan 4, 2022
    M
    Recruiting
    • B Acute Lymphoblastic Leukemia
    • B Lymphoblastic Lymphoma
    • Blinatumomab
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-02-21
    Feb 21, 2021
    M
    Active, not recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Allogeneic Bone Marrow Transplantation
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    2020-02-25
    Feb 25, 2020